Skip to content

Poppe Apotheek

Active Private limited companyfounded 2012active for 13 yearsDenderstraat 14, 9300 AalstKBO/BCE: BE 0508.613.263

Lifetime

12 annual accounts with figures on one time axis
peak of €126,093 in 2020
€123,128▲ 5.6%
lowest -€141,114 in 2015
€52,615▲ 9.7%
peak of €163,791 in 2025
€163,791▲ 45.1%
€452,372▼ 22.2%
peak of 0 FTE in 2023
-not published
Board5 names since 2012
5 directors and 4 others
Documentsfilings and deeds
23-12-202539 days before the deadline
2025micro format
Dividend €1,718Equity from €112,894 to €163,791Debts from €581,572 to €452,372Cash from €120,753 to €221,243

Key points

from the 2025 annual accounts

Equity

€163,791 ▲ 45.1%

Poppe Apotheek has made a profit without a break since 2018.

Turnover

≈ €430,000 estimated

The accounts state no turnover.

Debts

€452,372 73% of the balance sheet
Financial debts 67%Suppliers 10%Taxes and wages 1%Other 22%

Of this, €141,408 falls due within a year.

Liquidity

2.74 was 1.87 in 2024

Short-term debts fell from €230,072 to €141,408.

Filings

12 annual accounts since 2014
deadline201520202025

The last five annual accounts were filed 0 to 43 days before the end of the period.

Position in the sector

€52,615

Higher net result than 89% of companies in retail trade. Sector median €4,757 · 25,309 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,609 companies had the same profile as Poppe Apotheek has now. Each dot stands for 7 companies, two years later.

96.8%
were still trading
2.1%
stopped another way
1.0%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,609 companies, not a prediction for Poppe Apotheek. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 13-12-2012
Manager, since 13-12-2012
Director, since 13-12-2012
Manager, since 13-12-2012
Director, since 01-07-2024
  • 150 sharesdeed of 24-12-2012
  • 150 sharesdeed of 24-12-2012
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0508613263
appointed as director General meeting of 11-06-2024 · Gazette deed
(director) and (director) appointed Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 27-10-2022 · Gazette deed
Registered office moved within Aalst The registered office moved from Denderstraat 14 te 9300 Aalst to Denderstraat 14 A te 9300 Aalst · General meeting of 02-04-2015 · Gazette deed
All 24 events

Comparable companies

same main activity, similar in size and age
Company
Poppe Apotheek Aalst €616,163 €123,128 26.6% -
EMANUEL - VAN HAUWERMEIREN Dendermonde €588,306 €113,814 32.5% 1.5
Apotheek de Merode Mechelen €648,325 €124,252 49.3% 0.7
APOTHEEK DUCHATEAU Genk €632,398 €128,933 53.6% 0
VASSEUR-SEVRIN Chastre €567,446 €128,596 71.1% -
INFIPHAR Tienen €565,355 €117,065 17.2% 0
APOTHEEK DEBRUYNE ELLEN Knokke-Heist €656,346 €135,144 23.6% 0.5

These companies have the same main activity as Poppe Apotheek: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €565,000 and €656,000, founded between 2011 and 2013.

Official details

Source: KBO
Status
Active since 20-12-2012Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.215.016.6759300 Aalst, since 27-12-2012
Financial year end
30 June
Peppol
Reachable since 03-10-2025
Company details

Annual accounts to 30-06-2025

€616,163▼ 11.3%
Filing
Filed on 23-12-2025, 39 days before the end of the filing period
Financials

Insights on Poppe Apotheek

Poppe Apotheek files the micro format. That format states no turnover. The gross margin rose from €38,335 in 2014 to €123,128 in 2025.

The balance sheet grew most in 2015 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Poppe Apotheek

What is the company number of Poppe Apotheek?
The company number of Poppe Apotheek is 0508.613.263. The VAT number is the same number with BE in front: BE 0508.613.263.
Where is Poppe Apotheek based?
The registered office is at Denderstraat 14, 9300 Aalst.Company details
What does Poppe Apotheek do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Poppe Apotheek?
Poppe Apotheek is a private limited company (BV).
When was Poppe Apotheek founded?
Poppe Apotheek was founded on 20-12-2012.
Is Poppe Apotheek still active?
Yes, Poppe Apotheek is an active enterprise in the KBO register.
What is the turnover of Poppe Apotheek?
The turnover in financial year 2025 is ≈ €430,000. This figure is estimated from the gross margin of €123,128 and 38 comparable companies (NACE 477). It probably lies between €330,000 and €710,000.Financials
Is Poppe Apotheek profitable?
In financial year 2025, Poppe Apotheek made a profit of €52,615.
Where can I find the annual accounts of Poppe Apotheek?
Poppe Apotheek filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Poppe Apotheek due?
Poppe Apotheek must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.